C01-A039
Novichok Agents[edit]

Novichok agents are a series of advanced nerve agents developed by the Soviet Union and Russia between 1971 and 1993. These agents are part of a group of organophosphate compounds that are considered to be among the most toxic chemical warfare agents ever created.
History[edit]
The development of Novichok agents began during the Cold War as part of a program known as "FOLIANT." The goal was to create a new class of chemical weapons that would be undetectable by standard NATO chemical detection equipment and resistant to existing chemical protective gear.
Chemical Properties[edit]
Novichok agents are organophosphorus compounds, similar in structure to other nerve agents like Sarin and VX. However, they are designed to be more potent and to circumvent international chemical weapons treaties by being composed of binary components that are mixed to form the active agent.
Mechanism of Action[edit]
Novichok agents inhibit the enzyme acetylcholinesterase, leading to an accumulation of acetylcholine in the synaptic cleft. This results in continuous stimulation of muscles, glands, and central nervous system structures, causing symptoms such as muscle spasms, paralysis, and potentially death due to respiratory failure.
Symptoms of Exposure[edit]
Exposure to Novichok agents can cause a range of symptoms, including:
- Miosis (constricted pupils)
- Muscle twitching and spasms
- Seizures
- Respiratory distress
- Loss of consciousness
Treatment[edit]
The treatment for Novichok poisoning is similar to that for other nerve agents and includes the administration of atropine and pralidoxime. Atropine acts as an antagonist to acetylcholine, while pralidoxime reactivates acetylcholinesterase.
International Response[edit]
The use of Novichok agents has been condemned by the international community. The Chemical Weapons Convention prohibits the use of chemical weapons, and efforts have been made to identify and destroy stockpiles of these agents.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian